OKYO Pharma Limited (OKYO)
NASDAQ: OKYO
· Real-Time Price · USD
2.61
-0.03 (-1.14%)
At close: Aug 15, 2025, 1:24 PM
OKYO Pharma Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q2 2025 | Q1 2025 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 178.22 | 178.22 |
Cost of Revenue | 3.19K | 4.56K | 5.97K | 7.63K | 6.77K | 5.78K | 4.7K | 19.57K | 19.18K | 28.36K | 28.49K | 15.14K | 14.53K | 10.22K | 9.29K | 6.31K |
Gross Profit | -3.19K | -4.6K | -6.01K | -7.67K | -6.81K | -5.78K | -4.7K | -19.57K | -19.18K | -28.36K | -28.49K | -15.14K | -14.53K | -10.22K | -9.12K | -6.14K |
Operating Income | -7.71K | -9.81K | -11.99K | -5.56M | -5.55M | -8.99M | -8.99M | -6.22M | -6.22M | -5.45M | -5.45M | -3.78M | -3.78M | -1.54M | -1.54M | -1.53M |
Interest Income | n/a | n/a | 39.99 | 39.99 | 39.99 | 39.99 | 0.37 | 0.37 | 0.74 | 0.74 | 0.60 | 0.80 | 0.63 | 19.09 | 37.33 | 37.14 |
Pretax Income | -8.46K | -10.24K | -12.09K | -5.54M | -5.54M | -9M | -9M | -6.21M | -6.21M | -5.57M | -5.57M | -3.99M | -3.99M | -1.68M | -1.68M | -518.09K |
Net Income | -7.09K | -9.57K | -12.12K | -5.54M | -5.54M | -8.41M | -8.41M | -5.43M | -5.43M | -5.35M | -5.35M | -3.97M | -3.97M | -1.61M | -1.61M | -1.54M |
Selling & General & Admin | 791.71K | n/a | n/a | 2.94M | 2.94M | 5.57M | 5.57M | 4.91M | 4.91M | 4.8M | 4.8M | 3.59M | 3.59M | 1.33M | 1.33M | 1M |
Research & Development | 4.52K | 5.25K | 6.02K | 2.61M | 2.6M | 3.42M | 3.42M | 1.3M | 1.3M | 620.25K | 619.88K | 176.99K | 176.84K | 204.52K | 204.55K | 515.86K |
Other Expenses | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 4.52K | 5.25K | 6.02K | 5.55M | 5.55M | 8.99M | 8.99M | 6.21M | 6.2M | 5.42M | 5.42M | 3.76M | 3.76M | 1.53M | 1.53M | 1.52M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.71K | 9.81K | 11.99K | 5.56M | 5.55M | 8.99M | 8.99M | 6.22M | 6.22M | 5.45M | 5.45M | 3.78M | 3.78M | 1.54M | 1.54M | 1.53M |
Income Tax Expense | 1.46K | 756.43 | 53.62 | 50.68 | 9.26 | -591K | -590.78K | -779.78K | -779.71K | -214.56K | -214.78K | -25.69K | -25.76K | -76.83K | -76.81K | -76.9K |
Shares Outstanding (Basic) | 33.57M | 33.57M | 25.71M | 25.71M | 22.87M | 22.87M | 21.64M | 21.64M | 16.12M | 16.12M | 14.01M | 14.01M | 10.55M | 10.55M | 10.15M | 10.15M |
Shares Outstanding (Diluted) | 33.57M | 33.57M | 25.71M | 25.71M | 22.87M | 22.87M | 21.64M | 21.64M | 16.12M | 16.12M | 14.01M | 14.01M | 10.55M | 10.55M | 10.14M | 10.14M |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.26 | -0.26 | -0.44 | -0.44 | -0.36 | -0.36 | -0.45 | -0.45 | -0.38 | -0.38 | -0.16 | -0.16 | -0.18 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.26 | -0.26 | -0.44 | -0.44 | -0.36 | -0.36 | -0.45 | -0.45 | -0.38 | -0.38 | -0.16 | -0.16 | -0.18 |
EBITDA | -7.7K | -9.88K | -12.06K | -5.55M | -5.55M | -8.99M | -8.99M | -6.21M | -6.21M | -5.42M | -5.42M | -3.77M | -3.77M | -1.53M | -1.53M | -1.52M |
EBIT | -7.71K | -9.89K | -12.07K | -5.54M | -5.54M | -9M | -9M | -6.21M | -6.21M | -5.57M | -5.56M | -3.99M | -3.99M | -1.68M | -1.68M | -517.01K |
Depreciation & Amortization | 1.28K | 2.71 | 3.18 | 1.67K | 1.66K | 1.66K | 1.66K | 16.54K | 16.54K | 26.66K | 26.66K | 13.31K | 13.31K | 9K | 9K | 6.02K |